National Infusion Center Association
“Experimental COVID-19 treatment aimed at keeping Ventura County residents out of hospitals” NICA President and CEO, Brian Nyquist, is quoted in this article expressing the importance […]
“Powerful New Tool Predicts COVID Trends” This article explores predictive analytics for predicting COVID-19 surges, and NICA is mentioned as one of the organizations helping to […]
“Lower valley hospital sees success with COVID-19 antibody treatments” This article explains how one local hospital in Sunnyside, Washington successful administered monoclonal antibodies to COVID-positive patients. […]
“NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression” This article mentions that under the […]
“High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression Online Live CME Accredited Webinars” This article mentions NICA as a key resource for clinicians looking to […]
“COVID antibody treatments going unused in WA state as hospitals fill up, DOH says” As pandemic-related hospitalizations increase as a result of the Delta-variant of COVID-19, […]
By: Tiffani Bouchard, CCS Managing JW and JZ Modifiers When Billing Single-Dose Drugs Managing JW and JZ modifiers when billing single-dose drugs can be challenging. As […]
By: Pamela McIntyre, CRNI, IgCN, OCN, and VA-BC Maximizing Efficiency in Ambulatory Infusion Centers When it comes to maximizing efficiency in ambulatory infusion centers, one of […]
By: Michael Rigas, Pharm.D., FNHIA Biosimilars are also known as follow-on biologics or subsequent-entry biologics. They are FDA-approved copies of the original “innovator” drug product that […]